title: Which Is the Optimal Extent of Resection in Middle Third Gastric Cancer between Total Gastrectomy and Subtotal Gastrectomy?
abstract: OBJECTIVE
  In resectable gastric cancer, choice regarding the extent of resection depends on tumor size, location, and distance from resection margin. However, there remains controversy for choice of resection for tumors in the middle third of the stomach. This study investigated patients who underwent gastrectomy in order to analyze the differences between total gastrectomy (TG) and subtotal gastrectomy (STG).
  
  
  METHODS
  From 2000 to 2006, 125 patients with a tumor in the middle third of the stomach underwent radical gastric resection at EUMC. We retrospectively conducted comparative analysis for the differences in clinicopathological characteristics and prognosis between TG and STG.
  
  
  RESULTS
  The average tumor size was 6.7 cm for TG, and 4.1 cm for STG. The number of metastatic lymph nodes were 13.3 for TG, and 3.7 for STG. Patients with more advanced cancer were more likely to receive TG. The 5-year survival rate for TG was lower (38.1%) than STG (69.0%). However, if tumor stages were stratified, there was no significant difference in the survival rate. Histologically, for the undifferentiated type of cancer (Stage 1, 2), the 5-year survival rate of STG was higher (88.1%) than TG (75.0%).
  
  
  CONCLUSIONS
  Comparing patients with tumors in the middle third of the stomach who underwent TG and STG, there was no statistically significant difference in the 5-year survival rate. If stages were stratified, the clinicopathological characteristic becomes a key factor in deciding the prognosis, rather than the choice of resection. Thus if the radical resection margin can be obtained for a tumor in the middle third of the stomach, STG is considered instead of TG.
authors.affiliation: Department of Surgery, School of Medicine, Ewha Womans University, Seoul, Korea.
authors.forename: Ji Hyun
authors.initials: JH
authors.lastname: Lee
authors.forename: Yong Il
authors.initials: YI
authors.lastname: Kim
references.citation: Curr Probl Surg. 2006 Aug-Sep;43(8-9):566-670
references.pmid: 17000267
references.citation: Ann Surg. 1997 Nov;226(5):613-20
references.pmid: 9389395
references.citation: J Surg Oncol. 2010 May 1;101(6):451-6
references.pmid: 19924722
references.citation: Ann Surg. 2005 Jan;241(1):27-39
references.pmid: 15621988
references.citation: Nutrition. 1990 Sep-Oct;6(5):371-5
references.pmid: 2134560
references.citation: Hepatogastroenterology. 1996 Jan-Feb;43(7):187-93
references.pmid: 8682460
references.citation: Ann Surg Oncol. 2010 May;17(5):1259-66
references.pmid: 20217252
references.citation: World J Surg. 1998 Oct;22(10):1048-55
references.pmid: 9747165
references.citation: Ann Surg. 1999 Aug;230(2):170-8
references.pmid: 10450730
references.citation: Ann Surg. 1989 Feb;209(2):162-6
references.pmid: 2644898
references.citation: Cancer Prev Control. 1998 Dec;2(6):262-8
references.pmid: 10470455
references.citation: Surg Oncol Clin N Am. 2002 Apr;11(2):405-14
references.pmid: 12424859
references.citation: Ann Surg. 1982 Dec;196(6):685-90
references.pmid: 7149820
references.citation: Ann Surg. 1974 Aug;180(2):252-6
references.pmid: 4601986
references.citation: Cancer. 2006 Dec 1;107(11):2576-80
references.pmid: 17075877
references.citation: Cancer. 2001 Apr 15;91(8 Suppl):1589-92
references.pmid: 11309755